المؤلفون: Esposito TVF; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada., Blackadar C; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada., Wu L; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.; Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, Shenyang 110016, China., Rodríguez-Rodríguez C; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.; Department of Physics and Astronomy, Faculty of Science, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada., Haney EF; Centre for Microbial Disease and Immunity Research, Department of Microbiology and Immunology, Faculty of Science, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.; Asep Medical Holdings, 420 - 730 View Street, Victoria V8W 3Y7, British Columbia, Canada., Pletzer D; Centre for Microbial Disease and Immunity Research, Department of Microbiology and Immunology, Faculty of Science, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.; Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New Zealand., Saatchi K; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada., Hancock REW; Centre for Microbial Disease and Immunity Research, Department of Microbiology and Immunology, Faculty of Science, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada., Häfeli UO; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 1172, Denmark.

المصدر: Molecular pharmaceutics [Mol Pharm] 2024 Jun 03; Vol. 21 (6), pp. 2751-2766. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Gallium Radioisotopes*/pharmacokinetics , Gallium Radioisotopes*/chemistry , Gallium Radioisotopes*/administration & dosage, Animals ; Tissue Distribution ; Mice ; Lung/metabolism ; Lung/drug effects ; Peptides/chemistry ; Peptides/pharmacokinetics ; Female ; Nanoparticles/chemistry ; Mice, Inbred C57BL ; Male ; Immunity, Innate/drug effects ; Antimicrobial Cationic Peptides/pharmacokinetics ; Antimicrobial Cationic Peptides/chemistry

المؤلفون: Ogawa K; Institute for Frontier Science Initiative, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.; Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan., Nishizawa K; Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan., Mishiro K; Institute for Frontier Science Initiative, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan., Effendi N; Institute for Frontier Science Initiative, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.; Faculty of Pharmacy, Universitas Muslim Indonesia, Urip Sumiharjo KM. 10, Makassar 90-231, Indonesia., Fuchigami T; Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan., Munekane M; Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan., Wakabayashi H; Department of Nuclear Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Takara-machi 13-1, Kanazawa, Ishikawa 920-8641, Japan., Kinuya S; Department of Nuclear Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Takara-machi 13-1, Kanazawa, Ishikawa 920-8641, Japan.

المصدر: Molecular pharmaceutics [Mol Pharm] 2024 May 06; Vol. 21 (5), pp. 2375-2382. Date of Electronic Publication: 2024 Apr 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Gallium Radioisotopes*/pharmacokinetics , Gallium Radioisotopes*/chemistry , Radiopharmaceuticals*/pharmacokinetics , Tomography, Emission-Computed, Single-Photon*/methods , Bone and Bones*/diagnostic imaging , Bone and Bones*/metabolism, Animals ; Mice ; Tissue Distribution ; Peptides/chemistry ; Durapatite/chemistry ; Male ; Glutamic Acid/metabolism ; Female

المؤلفون: Zarei M; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden. maryam.zarei@umu.se., Wallsten E; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden., Grefve J; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden., Söderkvist K; Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden., Gunnlaugsson A; Skane University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden., Sandgren K; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden., Jonsson J; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden., Keeratijarut Lindberg A; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden., Nilsson E; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden., Bergh A; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden., Zackrisson B; Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden., Moreau M; Skane University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden., Thellenberg Karlsson C; Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden., Olsson LE; Department of Translational Medicine, Medical Radiation Physics, Lund University, Malmö, Sweden., Widmark A; Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden., Riklund K; Department of Diagnostics and Intervention, Diagnostic Radiology, Umeå University, Umeå, Sweden., Blomqvist L; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Sweden., Berg Loegager V; Department of Radiology, Copenhagen University Hospital in Herlev, Herlev, Denmark., Axelsson J; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden., Strandberg SN; Department of Diagnostics and Intervention, Diagnostic Radiology, Umeå University, Umeå, Sweden., Nyholm T; Department of Diagnostics and Intervention, Biomedical engineering and Radiation Physics, Umeå University, Umeå, Sweden.

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Jun 23; Vol. 63, pp. 503-510. Date of Electronic Publication: 2024 Jun 23.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/diagnostic imaging , Gallium Radioisotopes* , Tumor Burden* , Gallium Isotopes*, Humans ; Male ; Positron-Emission Tomography/methods ; Aged ; Prostatectomy ; Middle Aged ; Radiopharmaceuticals ; Oligopeptides ; Magnetic Resonance Imaging/methods ; Edetic Acid/analogs & derivatives

المؤلفون: Bentestuen M; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Hobrovej 18- 22, Aalborg, DK-9000, Denmark. m.bentestuen@rn.dk.; Department of Clinical Medicine, Aalborg University, Sdr. Skovvej 11, Aalborg, DK-9000, Denmark. m.bentestuen@rn.dk., Ladekarl M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Hobrovej 18-22, Aalborg, DK- 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Sdr. Skovvej 11, Aalborg, DK-9000, Denmark., Knudsen A; Department of Gynecology and Obstetrics, Aalborg University Hospital, Reberbansgade 15, Aalborg, DK-9000, Denmark.; Department of Clinical Medicine, Aalborg University, Sdr. Skovvej 11, Aalborg, DK-9000, Denmark., Zacho HD; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Hobrovej 18- 22, Aalborg, DK-9000, Denmark.; Department of Clinical Medicine, Aalborg University, Sdr. Skovvej 11, Aalborg, DK-9000, Denmark.

المصدر: BMC cancer [BMC Cancer] 2024 Jun 07; Vol. 24 (1), pp. 699. Date of Electronic Publication: 2024 Jun 07.

نوع المنشور: Journal Article; Clinical Trial Protocol

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography*/methods , Ovarian Neoplasms*/diagnostic imaging , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/drug therapy , Neoplasm Staging* , Fluorodeoxyglucose F18* , Gallium Radioisotopes*, Humans ; Female ; Prospective Studies ; Radiopharmaceuticals ; Middle Aged ; Adult ; Aged ; Quinolines

المؤلفون: Kline B; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Yadav S; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Seo Y; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Ippisch RC; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Castillo J; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Aggarwal RR; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Kelley RK; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Behr SC; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Flavell RR; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Lawhn-Heath C; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Melisko M; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Rugo HS; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Wang V; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Yom SS; Department of Radiation Oncology, University of California San Francisco, San Francisco, California., Ha P; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California; and., Jiang F; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California; thomas.hope@ucsf.edu.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Jun 03; Vol. 65 (6), pp. 938-943. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Fluorodeoxyglucose F18*/pharmacokinetics , Neoplasms*/diagnostic imaging , Neoplasms*/metabolism , Positron-Emission Tomography*/methods , Radiometry* , Gallium Radioisotopes*, Humans ; Male ; Female ; Middle Aged ; Tissue Distribution ; Aged ; Adult ; Radiopharmaceuticals/pharmacokinetics ; Aged, 80 and over ; Quinolines

المؤلفون: Qi C; Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Guo R; Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Chen Y; Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Li C; Medical Isotopes Research Center, Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing, China; and., Liu C; Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Zhang M; Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Zhang C; Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Zhang X; Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Hou X; Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Chen B; Chengdu AlpVHHs Co. Ltd., Chengdou, China., Jia B; Medical Isotopes Research Center, Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing, China; and., Yang Z; Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China., Shen L; Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China; zhuhuabch@pku.edu.cn shenlin@bjmu.edu.cn., Zhu H; Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China; zhuhuabch@pku.edu.cn shenlin@bjmu.edu.cn.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Jun 03; Vol. 65 (6), pp. 856-863. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Claudins*/metabolism , Gastrointestinal Neoplasms*/diagnostic imaging , Gastrointestinal Neoplasms*/metabolism , Gallium Radioisotopes* , Whole Body Imaging*, Humans ; Animals ; Mice ; Cell Line, Tumor ; Female ; Male ; Tissue Distribution ; Middle Aged ; Positron-Emission Tomography/methods ; Positron Emission Tomography Computed Tomography/methods ; Aged ; Radiopharmaceuticals/pharmacokinetics

المؤلفون: Duan H; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and., Song H; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and., Davidzon GA; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and., Moradi F; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and., Liang T; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and., Loening A; Division of Body MRI, Department of Radiology, Stanford University, Stanford, California., Vasanawala S; Division of Body MRI, Department of Radiology, Stanford University, Stanford, California., Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and aiagaru@stanford.edu.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Jun 03; Vol. 65 (6), pp. 897-903. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article; Comparative Study; Clinical Trial, Phase II

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/diagnostic imaging , Prostatic Neoplasms*/metabolism , Magnetic Resonance Imaging* , Gallium Radioisotopes* , Positron-Emission Tomography*/methods, Humans ; Male ; Aged ; Prospective Studies ; Middle Aged ; Gallium Isotopes ; Oligopeptides ; Recurrence ; Neoplasm Recurrence, Local/diagnostic imaging ; Aged, 80 and over ; Radiopharmaceuticals ; Edetic Acid/analogs & derivatives ; Multimodal Imaging

المؤلفون: Santo G; Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.; Department of Experimental and Clinical Medicine, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy., Di Santo G; Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria., Zelger B; Pathology, Medical University of Innsbruck, Innsbruck, Austria., Virgolini I; Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.

المصدر: Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2024 Jun; Vol. 63 (3), pp. 219-220. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Thieme Country of Publication: Germany NLM ID: 7609387 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-6407 (Electronic) Linking ISSN: 00295566 NLM ISO Abbreviation: Nuklearmedizin Subsets: MEDLINE

مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography* , Gallium Radioisotopes* , Gallium Isotopes* , Pancreatic Neoplasms*/diagnostic imaging , Pancreatic Neoplasms*/radiotherapy , Incidental Findings* , Adenocarcinoma*/diagnostic imaging , Adenocarcinoma*/radiotherapy , Lutetium*/therapeutic use, Humans ; Male ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Prostatic Neoplasms, Castration-Resistant/radiotherapy ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/pathology ; Edetic Acid/analogs & derivatives ; Radiopharmaceuticals/therapeutic use ; Aged ; Oligopeptides ; Prostate-Specific Antigen

عنوان ترانسليتريتد: Einfluss der 68Ga-PSMA-PET/CT auf die Bestrahlungsplanung beim Prostatakarzinom.

المؤلفون: Bock F; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Frerker B; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Schubert L; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Rennau H; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Kurth J; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Krause BJ; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Hildebrandt G; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Schwarzenböck SM; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.

المصدر: Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2024 Jun; Vol. 63 (3), pp. 199-206. Date of Electronic Publication: 2024 Apr 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Thieme Country of Publication: Germany NLM ID: 7609387 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-6407 (Electronic) Linking ISSN: 00295566 NLM ISO Abbreviation: Nuklearmedizin Subsets: MEDLINE

مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography* , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/diagnostic imaging , Prostatic Neoplasms*/pathology , Gallium Radioisotopes* , Gallium Isotopes* , Radiotherapy Planning, Computer-Assisted*/methods , Edetic Acid*/analogs & derivatives , Oligopeptides*, Humans ; Male ; Aged ; Middle Aged ; Aged, 80 and over ; Radiopharmaceuticals/therapeutic use ; Treatment Outcome

المؤلفون: Banihashemian SS; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Divband G; Khatam PET-CT Center, Khatam Hospital, Tehran, Iran., Pirayesh E; Department of Nuclear Medicine, School of Medicine, Shohada'E Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Nikkholgh B; Khatam PET-CT Center, Khatam Hospital, Tehran, Iran., Amini H; Khatam PET-CT Center, Khatam Hospital, Tehran, Iran., Shahrnoy AA; Parsisotope Company, Tehran, Iran., Nami R; Parsisotope Company, Tehran, Iran., Akbari ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. profmeakbari@gmail.com.

المصدر: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jun; Vol. 51 (7), pp. 1981-1988. Date of Electronic Publication: 2024 Feb 20.

نوع المنشور: Journal Article; Clinical Trial

بيانات الدورية: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography*/methods , Neoplasm Metastasis* , Neoplasms*/diagnostic imaging , Gallium Radioisotopes*, Humans ; Middle Aged ; Female ; Male ; Aged ; Adult ; Radiopharmaceuticals/pharmacokinetics ; Peptides, Cyclic/pharmacokinetics ; Peptides, Cyclic/chemistry ; Membrane Proteins ; Endopeptidases